• Portfolio
  • Latest Articles

BIOTECHNOLOGY

February 18th

New Portfolio Addition: Arovella Therapeutics

Earlier than Expected - DXB Gets First Regulatory Approval in Europe.

February 1st 2022

Earlier than Expected - DXB Gets First Regulatory Approval in Europe.

eSense-Lab strikes JV to develop and a sell new range of terpene products

June 15th 2020

eSense-Lab strikes JV to develop and a sell new range of terpene products

GTG developing a genetic test in the fight against COVID-19

May 22nd 2020

GTG developing a genetic test in the fight against COVID-19

Plenty of run left in Genetic Signatures

May 11th 2020

Plenty of run left in Genetic Signatures

Proteomics awarded vital CE Mark registration for PromarkerD

April 16th 2020

Proteomics awarded vital CE Mark registration for PromarkerD

Genetic Signatures builds on SARS technology

March 30th 2020

Genetic Signatures builds on SARS technology

Regeneus surges on back of Progenza patent news

March 23rd 2020

Regeneus surges on back of Progenza patent news

Knee osteoarthritis treatment delivers Regeneus a A$1.6M milestone payment

March 20th 2020

Knee osteoarthritis treatment delivers Regeneus a A$1.6M milestone payment

Page 1 of 8 next >

Connect with us

EXPLORE

  • Finfeed Portfolio
  • Latest Articles
  • How It Works
  • Archived Articles
  • About StocksDigital
  • News
  • PORTFOLIOS

  • Next Investors
  • Catalyst Hunter
  • Wise-Owl
  • STOCKS

    FOLLOW OUR INVESTMENT COMMENTARY & ANALYSIS
      CUSTOMER NOTICE | PRIVACY POLICY | FINANCIAL SERVICES GUIDE | DISCLOSURE POLICY  
    The information in this website is general information only. Any advice is general advice only. Your personal objectives, financial situation or needs have not been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice. S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877).
    © 2021   |   AFSL (CAR No.433913)